New Releases from NCBI BookshelfEfgartigimod alfa (generalized myasthenia gravis): Benefit assessment according to §35a SGB V,: IQWiG Reports – Commission No. A24-36 [Internet].Efgartigimod alfa (generalized myasthenia gravis): Benefit assessment according to §35a SGB V,: IQWiG Reports – Commission No. A24-36 [Internet].By / October 28, 2024 Post Content
